Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05938036 · ClinicalTrials.gov registry record · Phase 2

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

A Phase 2 study of Acute Respiratory Distress Syndrome (ARDS), sponsored by Aqualung Therapeutics.

Active
Registry status
Phase 2
Development phase
15
Enrollment target
1
Study location

NCT05938036 is a Phase 2 study of Acute Respiratory Distress Syndrome (ARDS) that is active but no longer recruiting, run by Aqualung Therapeutics. The registered enrollment target is 15 participants, below the 17,733-participant average among 8 other Acute Respiratory Distress Syndrome (ARDS) trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05938036, a Phase 2 study of Acute Respiratory Distress Syndrome (ARDS), is active but no longer recruiting, sponsored by Aqualung Therapeutics.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

A Phase 2a, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of ALT-100mAb in patients with moderate to severe ARDS.

Conditions Studied

Acute Respiratory Distress Syndrome (ARDS)

Interventions

  • DRUG ALT-100 mAb
  • DRUG ALT-100 (Placebo)

Study Locations (1)

Arizona

  • Banner University of Arizona - Tucson

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-12-01
Est. Completion 2027-07-01
Phase Phase 2

Sponsor

Aqualung Therapeutics

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05938036

The ClinicalTrials.gov registry entry for NCT05938036 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,733-participant average among 8 other Acute Respiratory Distress Syndrome (ARDS) trials with a reported enrollment target (100% lower). The listed sponsor is Aqualung Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Respiratory Distress Syndrome (ARDS) appearing as the primary indexed condition, and to 2 interventions - of which ALT-100 mAb is the first listed.

NCT05938036 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05938036 about?

NCT05938036 is a clinical study titled "Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS". A Phase 2a, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of ALT-100mAb in patients with moderate to severe ARDS.

What is the current status of trial NCT05938036?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2023-12-01. Estimated completion is 2027-07-01.

What conditions does trial NCT05938036 study?

This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome (ARDS).

What interventions are being tested in trial NCT05938036?

The interventions under investigation include: ALT-100 mAb (DRUG), ALT-100 (Placebo) (DRUG).

Who is sponsoring clinical trial NCT05938036?

This trial is sponsored by Aqualung Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05938036 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Respiratory Distress Syndrome (ARDS)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Respiratory Distress Syndrome (ARDS)

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.